Active Recombinant Human FAM19A2

• Cat.No.: FAM19A2-319H
• Product Overview: Recombinant Human FAM19A2 (Accession # AAH28403) Ala31-His131 was produced in E. coli-derived.

Specification

• Source: E. coli
• Species: Human
• Predicted N Terminal: Ala31
• Form: Lyophilized from a 0.2 µm filtered solution in PBS.
• Bio-activity: Measured by its ability to enhance neurite outgrowth of E16-E18 rat embryonic cortical neurons.rhTAFA2, immobilized at 6 - 24 µg/mL on a 96-well plate, is able to significantly enhance neurite outgrowth.
• Molecular Mass: Recombinant Human FAM19A2 has a calculated MW of 11.3 kDa. In SDS-PAGE migrates as 11 kDa, reducing conditions.
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).

Gene Information

• Gene Name: FAM19A2 family with sequence similarity 19 (chemokine (C-C motif)-like), member A2 [ Homo sapiens ]
• Official Symbol: FAM19A2
• Synonyms: FAM19A2; family with sequence similarity 19 (chemokine (C-C motif)-like), member A2; protein FAM19A2; TAFA 2; chemokine-like protein TAFA-2; TAFA2; TAFA-2; MGC42403; DKFZp761E1217; DKFZp781P0552
• Gene ID: 338811
• mRNA Refseq: NM_178539
• Protein Refseq: NP_848634
• UniProt ID: Q8N3H0
• Chromosome Location: 12q14.1